MRE-269, CAS [[475085-57-5]]

Produktübersicht

• Artikelname: MRE-269, CAS [[475085-57-5]]
• Artikelnummer: BYT-ORB1303362
• Hersteller Artikelnummer: orb1303362
• Alternativnummer: BYT-ORB1303362-1, BYT-ORB1303362-10, BYT-ORB1303362-100, BYT-ORB1303362-25, BYT-ORB1303362-5, BYT-ORB1303362-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: ACT 333679, ACT-333679, ACT333679, MRE 269, MRE269, MRE-269, inhibit, Inhibitor, ProstaglandinReceptor, prostaglandin I2 receptor, Prostaglandin Receptor

Produktbeschreibung

MRE-269 (ACT-333679) is the long-acting, orally active metabolite of Selexipag and a potent prostacyclin receptor (IP receptor) agonist. It is utilized in pulmonary arterial hypertension (PAH) research, with studies demonstrating its efficacy in both in vitro assays and in vivo animal models of pulmonary hypertension.

Produkteigenschaften

• Molekulargewicht: 419.52
• Reinheit: 99.57% (May vary between batches)
• CAS Nummer: [475085-57-5]
• Formel: C25H29N3O3
• Target-Kategorie: Prostaglandin Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:55 mg/mL (131.1 mM),10% DMSO+90% Corn Oil:2.5 mg/mL (5.96 mM)